Chicago Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Chicago Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-295,864	Closed	-$11.1M	–	51
2021 Q1	$11.1M	Buy	+295,864	New	+$7.38M	5.19%	9

Chicago Capital Management's FPRX Position: Q2 2021 in Review

Chicago Capital Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 295,864 shares — an estimated $11.1M sold.

Chicago Capital Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $11.1M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Chicago Capital Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Chicago Capital Management sold 295,864 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $11.1M.
Chicago Capital Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Chicago Capital Management's Five Prime Therapeutics, Inc. position peaked at $11.1M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Chicago Capital Management's 13F filing for Q2 2021, filed 11 Aug 2021.